Alzheimer & Parkinson Disease
167. Hammock, B.D., A.M. Beale, T. Work, S.J. Gee, R. Gunther, R.J. Higgins, T. Shinka and N.J.R. Castagnoli. 1989. A sheep model for MPTP induced Parkinson-like symptoms. Life Sci. 45:1601-1608. doi: https://doi.org/10.1016/0024-3205(89)90427-x [Download]
176. Beale, A.M., R.J. Higgins, T.M. Work, C.S. Bailey, M.O. Smith, T. Shinka and B.D. Hammock. 1989. MPTP-induced Parkinson-like disease in sheep: Clinical and pathologic findings. J. Env. Path. Toxicol. Oncol. 9(5-6):417-428. [Download]
997. Inceoglu B, Bettaieb A, Trindade da Silva CA, Lee KS, Haj FG, Hammock BD. 2015. Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain. Proceedings of the National Academy of Sciences of the United States of America. 112(29):9082-9087. doi: 10.1073/pnas.1510137112. [Download]
1036. Lakkappa, N., P.T. Krishnamurthy, M.M.S. Bharath, D. Velmurugan, B.D. Hammock and S. Mulukutla. 2016 Aug. Possible role of epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders. Med Hypotheses. 93(2016):161-5. doi: https://doi.org/10.1016/j.mehy.2016.06.003. [Download]
1054. Zhang, Y., G. Hong, K.S.S. Lee, B.D. Hammock, D. Gebremedhin, D.R. Harder, R.C. Koehler and A. Sapirstein. Epub ahead of print. 2016 Dec. Inhibition of soluble epoxide hydrolase augments astrocyte release of vascular endothelial growth factor and neuronal recovery after oxygen-glucose deprivation. J Neurochem. 140(5): 814-825. 2017 Jan 23. Doi: 10.1111/jnc.13933 . [Download]
1057. Hennebelle, M., Y. Otoki, J. Yang, B.D. Hammock, A.J. Levitt, A.Y. Taha and W. Swardfager. 2016. Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: an exploratory study. Psychiatry Res. 2017 Feb 27.252 (2017)94-101. Doi: https://doi.org/10.1016/j.psychres.2017.02.056. [Download]
1059. Wagner, K., J. Gilda, J. Yang, C. Morisseau, A. Gomez and B.D. Hammock. 2016. Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice. Behavioural Brain Research. 2017 Mar 1:326:69-76. Doi:https://doi.org/10.1016/j.bbr.2017.02.048. [Download]
1062. M. Fiala, G. Kooij, K. Wagner, B.D. Hammock, M. Pellegrini and M. Pellegrini. 2017. Modulation of innate immunity of patients with Alzheimer’s disease by omega-3 fatty acids. FASEB. 31(8): 3229-39. 2017 April 18. doi: https://doi.org/10.1096/fj.201700065r. [Download]
1073. Hennebelle M, Zhang Z, Metherel AH, Kitson AP, Otoki Y, Richardson CE, Yang J, Lee KSS, Hammock BD, Zhang L, Bazinet RP, Taha AY. 2017. Linoleic acid participates in the response to ischemic brain injury through oxidized metabolites that regulate neurotransmission. Scientific reports. DOI: https://doi.org/10.1038/s41598-017-02914-7. [Download]
1079. Wagner, K.M., K.S.S. Lee, J. Yang and B.D. Hammock. 2016. Epoxy fatty acids mediate analgesia in murine diabetic neuropathy. Eur J Pain. Epub ahead of print Sep 2016. doi: https://doi.org/10.1002/ejp.939. [Download]
1105. Wagner KM, McReynolds CB, Schmidt WK, Hammock BD. 2017. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol Ther. doi:https://doi.org/10.1016/j.pharmthera.2017.06.006. [Download]
1107. Navya Lakkappa, Praveen T. Krishnamurthy, Karthik Yamjala, Sung Hee Hwang, Bruce D. Hammock, B. Babu. Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC–MS/MS method development. Journal of Pharmaceutical and Biomedical Analysis. doi: https://doi.org/10.1016/j.jpba.2017.11.043. [Download]
1115. Tu R, Armstrong J, Lee KSS, Hammock BD, Sapirstein A, Koehler RC. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. Scientific Reports. 2018;8(1):5279. doi: 10.1038/s41598-018-23504-1. [Download]
1122. Ren Q, Ma M, Yang J, Nonaka R, Yamaguchi A, Ishikawa KI, Kobayashi K, Murayama S, Hwang SH, Saiki S, Akamatsu W, Hattori N, Hammock BD, Hashimoto K. 2018. Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A. 115(25):E5815-e23. doi: 10.1073/pnas.1802179115. [Download]
1144. Pardeshi R, Bolshette N, Gadhave K, Arfeen M, Ahmed S, Jamwal R, Hammock BD, Lahkar M, Goswami SK. Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes. Frontiers in pharmacology. 2019;10(288). doi: 10.3389/fphar.2019.00288. [Download]
1151. Lakkappa N, Krishnamurthy PT, M DP, Hammock BD, Hwang SH. 2019. Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease. Neurotoxicology. 70:135-45. doi: 10.1016/j.neuro.2018.11.010. [Download]
1158. Cam M, Durieu E, Bodin M, Manousopoulou A, Koslowski S, Vasylieva N, Barnych B, Hammock BD, Bohl B, Koch P, Omori C, Yamamoto K, Hata S, Suzuki T, Karg F, Gizzi P, Erakovic Haber V, Bencetic Mihaljevic V, Tavcar B, Portelius E, Pannee J, Blennow K, Zetterberg H, Garbis SD, Auvray P, Gerber H, Fraering J, Fraering PC, Meijer L. 2018. Induction of Amyloid-beta42 Production by Fipronil and Other Pyrazole Insecticides. J Alzheimers Dis. 62(4):1663-81. doi: 10.3233/jad-170875. [Download]
1160. Swardfager W, Hennebelle M, Yu D, Hammock BD, Levitt AJ, Hashimoto K, Taha AY. 2018. Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. Neurosci Biobehav Rev. 87:56-66. doi: 10.1016/j.neubiorev.2018.01.010. [Download]
1168. Zarriello S, Tuazon JP, Corey S, Schimmel S, Rajani M, Gorsky A, Incontri D, Hammock BD, Borlongan CV. 2019. Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders. Prog Neurobiol. 172:23-39. doi: 10.1016/j.pneurobio.2018.11.001. [Download]
1184. Liang Z, Zhang B, Xu M, Morisseau C, Hwang SH, Hammock BD, Li QX. 2019. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells. ACS Chem Neurosci. 10(9):4018-4030. 10.1021/acschemneuro.9b00271. [Download]
1187. Shen Y, Peng W, Chen Q, Hammock BD, Liu J, Li D, Yang J, Ding J, Wang X. 2019. Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model. Brain, Behavior, and Immunity. 81:535-544. doi: https://doi.org/10.1016/j.bbi.2019.07.014. [Download]
1188. Joshi U, Pearson A, Evans JE, Langlois H, Saltiel N, Ojo J, Klimas N, Sullivan K, Keegan AP, Oberlin S, Darcey T, Cseresznye A, Raya B, Paris D, Hammock B, Vasylieva N, Hongsibsong S, Stern LJ, Crawford F, Mullan M, Abdullah L. 2019. A permethrin metabolite is associated with adaptive immune responses in Gulf War Illness. Brain, Behavior, and Immunity. 81:545-559. doi: https://doi.org/10.1016/j.bbi.2019.07.015. [Download]
1195. Yang J, Bruun DA, Wang C, Wan D, Reynolds CB, Phu K, Inceoglu B, Lein PJ, Hammock BD. 2019. Lipidomes of brain from rats acutely intoxicated with diisopropylfluorophosphate identifies potential therapeutic targets. Toxicol Appl Pharmacol.114749. doi: 10.1016/j.taap.2019.114749. [Download]
1200. Wagner KM, Atone J, Hammock BD. 2019. Soluble epoxide hydrolase inhibitor mediated analgesia lacks tolerance in rat models. Brain Research.146573. doi: https://doi.org/10.1016/j.brainres.2019.146573. [Download]
1204. Li D, Morisseau C, McReynolds CB, Duflot T, Bellien J, Nagra RM, Taha AY, Hammock BD. 2020. Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis Patients. Analytical Chemistry. 92(10):7334-7342. doi: 10.1021/acs.analchem.0c01115. [Download]
1213. Pu Y, Yang J, Chang L, Qu Y, Wang S, Zhang K, Xiong Z, Zhang J, Tan Y, Wang X, Fujita Y, Ishima T, Wang D, Hwang SH, Hammock BD, Hashimoto K. 2020. Maternal glyphosate exposure causes autism-like behaviors in offspring through increased expression of soluble epoxide hydrolase. Proceedings of the National Academy of Sciences. doi: 117(21):11753. 10.1073/pnas.1922287117. [Download]
1218. Zhang J, Tan Y, Chang L, Hammock BD, Hashimoto K. 2020. Increased expression of soluble epoxide hydrolase in the brain and liver from patients with major psychiatric disorders: A role of brain - liver axis. J Affect Disord. 270:131-134. doi: 10.1016/j.jad.2020.03.070. [Download]
1244. Matin N, Fisher C, Lansdell TA, Hammock BD, Yang J, Jackson WF, Dorrance AM. 2020. Soluble epoxide hydrolase inhibition improves cognitive function and parenchymal artery dilation in a hypertensive model of chronic cerebral hypoperfusion. Microcirculation. n/a(n/a):e12653. doi: 10.1111/micc.12653. [Download]
1254. Hennebelle M, Metherel AH, Kitson AP, Otoki Y, Yang J, Lee KSS, Hammock BD, Bazinet RP, Taha AY. 2019. Brain oxylipin concentrations following hypercapnia/ischemia: effects of brain dissection and dissection time. Journal of lipid research. 60(3):671-682. doi: 10.1194/jlr.D084228. [Download]
1257. Griñán-Ferré C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, Puigoriol-Illamola D, Companys-Alemany J, Corpas R, Sanfeliu C, Pérez B, Loza MI, Brea J, Morisseau C, Hammock BD, Vázquez S, Pallàs M, Galdeano C. 2020. Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease. Neurotherapeutics. doi: 0.1007/s13311-020-00854-1. [Download]
1258. Ghosh A, Comerota MM, Wan D, Chen F, Propson NE, Hwang SH, Hammock BD, Zheng H. 2020. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease. Science Translational Medicine. 12(573):eabb1206. doi: 10.1126/scitranslmed.abb1206. [Download]
1260. Pressly B, Lee RD, Barnych B, Hammock BD, Wulff H. 2021. Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the α2β3γ2 GABA-A Receptor. Molecular Pharmacology. 99(1):78-91. doi: 10.1124/molpharm.120.000090. [Download]
1295. Jonnalagadda D, Wan D, Chun J, Hammock BD, Kihara Y. 2021. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis. Int J Mol Sci. 22(9). doi: 10.3390/ijms22094650. [Download]
1297. Wang S, Ishima T, Qu Y, Shan J, Chang L, Wei Y, Zhang J, Pu Y, Fujita Y, Tan Y, Wang X, Ma L, Wan X, Hammock BD, Hashimoto K. Ingestion of Faecalibaculum rodentium causes depression-like phenotypes in resilient Ephx2 knock-out mice: A role of brain-gut-microbiota axis via the subdiaphragmatic vagus nerve. J Affect Disord. 2021 Sep 1;292:565-573. doi: 10.1016/j.jad.2021.06.006. Epub 2021 Jun. [Download]
1307. Sun CP, Zhang XY, Zhou JJ, Huo XK, Yu ZL, Morisseau C, Hammock BD, Ma XC. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway. Food Chem Toxicol. 2021 Oct;156:112516. doi: 10.1016/j.fct.2021.112516. Epub 2021 Aug 16. [Download]
1332. Sun CP, Zhou JJ, Yu ZL, Huo XK, Zhang J, Morisseau C, Hammock BD, Ma XC. Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model. Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):e2118818119. doi: 10.1073/pnas.2118818119. [Download]
1334. Codony S, Pont C, Griñán-Ferré C, Di Pede-Mattatelli A, Calvó-Tusell C, Feixas F, Osuna S, Jarné-Ferrer J, Naldi M, Bartolini M, Loza MI, Brea J, Pérez B, Bartra C, Sanfeliu C, Juárez-Jiménez J, Morisseau C, Hammock BD, Pallàs M, Vázquez S, Muñoz-Torrero D. Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease. J Med Chem. 2022 Mar 24;65(6):4909-4925. doi: 10.1021/acs.jmedchem.1c02150. Epub 2022 Mar 10. [Download]
1349. Nguyen N, Morisseau C, Li D, Yang J, Lam E, Woodside DB, Hammock BD, Shih PB. Soluble Epoxide Hydrolase Is Associated with Postprandial Anxiety Decrease in Healthy Adult Women. Int J Mol Sci. 2022 Oct 5;23(19):11798. doi: 10.3390/ijms231911798. [Download]
1364. Dover M, Moseley T, Biskaduros A, Paulchakrabarti M, Hwang SH, Hammock B, Choudhury B, Kaczor-Urbanowicz KE, Urbanowicz A, Morselli M, Dang J, Pellegrini M, Paul K, Bentolila LA, Fiala M. Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease. J Alzheimers Dis. 2023;91(1):245-261. doi: 10.3233/JAD-220764. [Download]
1365. Atone J, Wagner K, Koike S, Yang J, Hwang SH, Hammock BD. Inhibition of soluble epoxide hydrolase reduces paraquat neurotoxicity in rodents. Environ Toxicol Pharmacol. 2023 Mar;98:104070. doi: 10.1016/j.etap.2023.104070. Epub 2023 Jan 20. [Download]
1370. Luo A, Wu Z, Li S, McReynolds CB, Wang D, Liu H, Huang C, He T, Zhang X, Wang Y, Liu C, Hammock BD, Hashimoto K, Yang C. The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling. J Transl Med. 2023 Feb 2;21(1):71. doi: 10.1186/s12967-023-03917-x. [Download]
1387. Wang W, Wang Y, Wagner KM, Lee RD, Hwang SH, Morisseau C, Wulff H, Hammock BD. Aflatoxin B1 Increases Soluble Epoxide Hydrolase in the Brain and Induces Neuroinflammation and Dopaminergic Neurotoxicity. Int J Mol Sci. 2023 Jun 9;24(12):9938. doi: 10.3390/ijms24129938. [Download]
1390. Dai Y, Dong J, Wu Y, Zhu M, Xiong W, Li H, Zhao Y, Hammock BD, Zhu X. Enhancement of the liver's neuroprotective role ameliorates traumatic brain injury pathology. Proc Natl Acad Sci U S A. 2023 Jun 27;120(26):e2301360120. doi: 10.1073/pnas.2301360120. Epub 2023 Jun 20. [Download]
1438. Hossain Hrithik MT, Shahmohammadi N, Jin G, Lee DH, Singh N, Vik A, Hammock BD, Kim Y. Insect immune resolution with EpOME/DiHOME and its dysregulation by their analogs leading to pathogen hypersensitivity. Insect Biochem Mol Biol. 2024 May;168:104104. doi: 10.1016/j.ibmb.2024.104104. Epub 2024 Mar 15. [Download]
1462. Tang C, Border JJ, Zhang H, Gregory A, Bai S, Fang X, Liu Y, Wang S, Hwang SH, Gao W, Morgan GC, Smith J, Bunn D, Cantwell C, Wagner KM, Morisseau C, Yang J, Shin SM, O'Herron P, Bagi Z, Filosa JA, Dong Y, Yu H, Hammock BD, Roman RJ, Fan F. Inhibition of Soluble Epoxide Hydrolase Ameliorates Cerebral Blood Flow Autoregulation and Cognition in Alzheimer's Disease and Diabetes-Related Dementia Rat Models. bioRxiv [Preprint]. 2024 Aug 31:2024.08.30.610540. doi: 10.1101/2024.08.30.610540. Update in: Geroscience. 2025 Jun;47(3):4429-4449. doi: 10.1007/s11357-025-01550-8. [ Download]
1470. Moradi F, Mokhtari T. Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease-A Review. J Biochem Mol Toxicol. 2025 Feb;39(2):e70071. doi: 10.1002/jbt.70071. [Download]
1473. Tang C, Border JJ, Zhang H, Gregory A, Bai S, Fang X, Liu Y, Wang S, Hwang SH, Gao W, Morgan GC, Smith J, Bunn D, Cantwell C, Wagner KM, Morisseau C, Yang J, Shin SM, O'Herron P, Bagi Z, Filosa JA, Dong Y, Yu H, Hammock BD, Roman RJ, Fan F. Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models. Geroscience. 2025 Jun;47(3):4429-4449. doi: 10.1007/s11357-025-01550-8. Epub 2025 Feb 4. [Download]
1476. Fiala M, Hammock BD, Hwang SH, Whitelegge J, Paul K, Kaczor-Urbanowicz KE, Urbanowicz A, Kesari S. Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease. J Alzheimers Dis. 2025 Mar;104(1):150-157. doi: 10.1177/13872877241305965. Epub 2025 Feb 17. [Download]
1480. Fang X, Border JJ, Zhang H, Challagundla L, Kaur J, Hwang SH, Hammock BD, Fan F, Roman RJ. A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer's Disease. Int J Mol Sci. 2025 Mar 8;26(6):2433. doi: 10.3390/ijms26062433. [Download]
1482. Nguyen N, Yang J, Morisseau C, Li D, German JB, Lam E, Woodside DB, Hammock BD, Shih PB. Differential Psychopathology Associations Found for Docosahexaenoic Acid versus Arachidonic Acid Oxylipins of the Cytochrome P450 Pathway in Anorexia Nervosa. medRxiv [Preprint]. 2025 Mar 3:2025.03.02.25323194. doi: 10.1101/2025.03.02.25323194. [Download].
1483. Wang S, Qi C, Rajpurohit C, Ghosh B, Xiong W, Wang B, Qi Y, Hwang SH, Hammock BD, Li H, Gan L, Zheng H. Inhibition of Soluble Epoxide Hydrolase Confers Neuroprotection and Restores Microglial Homeostasis in a Tauopathy Mouse Model. Res Sq [Preprint]. 2025 Feb 24:rs.3.rs-6038641. doi: 10.21203/rs.3.rs-6038641/v1. Update in: Mol Neurodegener. 2025 Apr 23;20(1):44. doi: 10.1186/s13024-025-00844-x. [Download]
1484. Bartra C, Vuraić K, Yuan Y, Codony S, Valdés-Quiroz H, Casal C, Slevin M, Máquez-Kisinousky L, Planas AM, Griñán-Ferré C, Pallàs M, Morisseau C, Hammock BD, Vázquez S, Suñol C, Sanfeliu C. Microglial pro-inflammatory mechanisms induced by monomeric C-reactive protein are counteracted by soluble epoxide hydrolase inhibitors. Int Immunopharmacol. 2025 Apr 10;155:114644. doi: 10.1016/j.intimp.2025.114644. [Download]
1489. Sun X, Liu H, Li W, Li L, Tian Q, Cao Q, Meng Y, Shen Y, Che F, Chiu JC, Yu J, Hammock BD. The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer's disease. J Inflamm (Lond). 2025 Jun 23;22(1):25. doi: 10.1186/s12950-025-00449-7. [Download]
1490. Wagner KM, Yang J, Morisseau C, Hammock BD. Inhibition of Soluble Epoxide Hydrolase Prevents Docetaxel-Induced Painful Peripheral Neuropathy. Int J Mol Sci. 2025 Jun 12;26(12):5630. doi: 10.3390/ijms26125630. [Download]
1495. Wang S, Qi C, Rajpurohit C, Ghosh B, Xiong W, Wang B, Qi Y, Hwang SH, Hammock BD, Li H, Gan L, Zheng H. Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model. Mol Neurodegener. 2025 Apr 23;20(1):44. doi: 10.1186/s13024-025-00844-x. [Download]
1500. Zhang J, Zhang HL, Xu XR, Feng YL, Zhu QM, Morisseau C, Qiu F, Hammock BD, Sun CP. Targeting PBK with small-molecule 1-O-acetyl-4R,6S-britannilactone for the treatment of neuroinflammation. Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2502593122. doi: 10.1073/pnas.2502593122. Epub 2025 Jul 14. [Download]
1506. Morgan GC, Gregory A, Tang C, Hwang SH, Border JJ, Xu J, Liu Y, Bai S, Lee TJ, Cantwell C, Bunn D, Wagner KM, Morisseau C, Pittman C, Ngo A, Osayi P, Pabbidi A, O'Herron P, Bagi Z, Filosa JA, Yu H, McReynolds C, Hammock BD, Roman RJ, Fan F. Dual Inhibition of sEH and COX-2 Improved Cognition in Alzheimer's Disease via Enhanced Myogenic Response and Cerebral Artery Distensibility. bioRxiv [Preprint]. 2025 Aug 26:2025.08.21.669945. doi: 10.1101/2025.08.21.669945. [Download].